Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy
暂无分享,去创建一个
E. Burchard | A. Kho | Sam S. Oh | S. Weiss | A. Dahlin | D. Croteau-Chonka | C. Eng | S. Lutz | Q. Lu | J. Rodriguez-Santana | A. Mak | J. Sordillo | M. McGeachie | K. Tantisira | R. Kelly | A. Wu | M. Seibold | S. Sajuthi | B. Raby | A. Wang | R. Panganiban | Cydney Urbanek | B. Saef | Damien C. Croteau-Chonka | S. Weiss | Ronald Panganiban
[1] K. Gruffydd-Jones. Unmet needs in asthma , 2019, Therapeutics and clinical risk management.
[2] S. Tufik,et al. Genes related to maintenance of autophagy and successful aging , 2018, Arquivos de Neuro-Psiquiatria.
[3] Jinhua Wang,et al. SGK1 inhibits PM2.5-induced apoptosis and oxidative stress in human lung alveolar epithelial A549 cells. , 2018, Biochemical and biophysical research communications.
[4] David Martínez ‐ Enguita. Identification of personalized multi-omic disease modules in asthma , 2018 .
[5] A. Dahlin,et al. A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor , 2017, Scientific Reports.
[6] D. Nicolae,et al. Gene Expression Profiling in Blood Provides Reproducible Molecular Insights into Asthma Control , 2017, American journal of respiratory and critical care medicine.
[7] P. Tsai,et al. Age-dependent changes in mean and variance of gene expression across tissues in a twin cohort , 2016, bioRxiv.
[8] Dexter Pratt,et al. NDEx: A Community Resource for Sharing and Publishing of Biological Networks. , 2017, Methods in molecular biology.
[9] M. Lombès,et al. Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance , 2016, Human mutation.
[10] F. Huang,et al. Role of BAF60a/BAF60c in chromatin remodeling and hepatic lipid metabolism , 2016, Nutrition & Metabolism.
[11] Cheng-Wen Wu,et al. MicroRNA-7 Compromises p53 Protein-dependent Apoptosis by Controlling the Expression of the Chromatin Remodeling Factor SMARCD1* , 2015, The Journal of Biological Chemistry.
[12] Andres Metspalu,et al. The transcriptional landscape of age in human peripheral blood , 2015, Nature Communications.
[13] E. Israel,et al. Impact of Age and Sex on Response to Asthma Therapy. , 2015, American journal of respiratory and critical care medicine.
[14] E. Bleecker,et al. Asthma pharmacogenetics and the development of genetic profiles for personalized medicine , 2015, Pharmacogenomics and personalized medicine.
[15] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[16] Scott T. Weiss,et al. RNA-Seq Transcriptome Profiling Identifies CRISPLD2 as a Glucocorticoid Responsive Gene that Modulates Cytokine Function in Airway Smooth Muscle Cells , 2014, PloS one.
[17] Christopher R. Gignoux,et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. , 2014, The Journal of allergy and clinical immunology.
[18] P. Chanez,et al. Bronchial epithelium as a target for innovative treatments in asthma. , 2013, Pharmacology & therapeutics.
[19] I Celardo,et al. Senescence and aging: the critical roles of p53 , 2013, Oncogene.
[20] Christopher R. Gignoux,et al. Factors associated with degree of atopy in Latino children in a nationwide pediatric sample: the Genes-environments and Admixture in Latino Asthmatics (GALA II) study. , 2013, The Journal of allergy and clinical immunology.
[21] E. Burchard,et al. Childhood obesity and asthma control in the GALA II and SAGE II studies. , 2013, American journal of respiratory and critical care medicine.
[22] Leopold Parts,et al. Gene expression changes with age in skin, adipose tissue, blood and brain , 2013, Genome Biology.
[23] Q. Hamid,et al. Glucocorticoid Receptor-Beta Up-Regulation and Steroid Resistance Induction by IL-17 and IL-23 Cytokine Stimulation in Peripheral Mononuclear Cells , 2012, Journal of Clinical Immunology.
[24] U. Potočnik,et al. Association among ORMDL3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthma , 2012, The Pharmacogenomics Journal.
[25] Yusuke Nakamura,et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. , 2011, The New England journal of medicine.
[26] Ryan D. Hernandez,et al. Meta-analysis of Genome-wide Association Studies of Asthma In Ethnically Diverse North American Populations , 2011, Nature Genetics.
[27] J. Ward,et al. Prosurvival activity for airway neutrophils in severe asthma , 2010, Thorax.
[28] L. Liang,et al. A genome-wide association study on African-ancestry populations for asthma. , 2010, The Journal of allergy and clinical immunology.
[29] C. Sorkness,et al. Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. , 2007, The Journal of allergy and clinical immunology.
[30] Vernon M Chinchilli,et al. The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. , 2004, Controlled clinical trials.
[31] Philip Marcus,et al. Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.
[32] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[33] D. Dorscheid,et al. Corticosteroid-induced apoptosis of airway epithelium: a potential mechanism for chronic airway epithelial damage in asthma. , 2002, Chest.
[34] M. Todaro,et al. Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects , 2002, European Respiratory Journal.
[35] G H Guyatt,et al. Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.
[36] S. Szefler,et al. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. , 1998, The Journal of allergy and clinical immunology.